PCA
WST icon

Pallas Capital Advisors’s West Pharmaceutical WST Stock Holding History

Pallas Capital Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.28M Sell
6,349
-10
-0.2% -$3.06K 0.07% 197
2026
Q1 		$1.59M Sell
6,359
-987
-13% -$246K 0.06% 235
2025
Q4 		$2.02M Buy
7,346
+26
+0.4% +$7.11K 0.07% 215
2025
Q3 		$1.92M Buy
7,320
+987
+16% +$240K 0.07% 215
2025
Q2 		$1.39M Buy
6,333
+62
+1% +$13.3K 0.05% 257
2025
Q1 		$1.4M Sell
6,271
-30
-0.5% -$8.27K 0.06% 240
2024
Q4 		$2.06M Buy
6,301
+8
+0.1% +$2.52K 0.09% 155
2024
Q3 		$2.08M Sell
6,293
-1
-0% -$306 0.09% 151
2024
Q2 		$1.99M Buy
6,294
+5
+0.1% +$1.77K 0.09% 153
2024
Q1 		$2.49M Sell
6,289
-6
-0.1% -$2.22K 0.1% 142
2023
Q4 		$2.22M Sell
6,295
-6
-0.1% -$2.12K 0.12% 134
2023
Q3 		$2.02M Buy
6,301
+11
+0.2% +$4.25K 0.12% 138
2023
Q2 		$2.41M Buy
6,290
+15
+0.2% +$5.36K 0.11% 114
2023
Q1 		$2.33M Sell
6,275
-3
-0% -$877 0.22% 88
2022
Q4 		$1.63M Sell
6,278
-57
-0.9% -$13.5K 0.16% 105
2022
Q3 		$1.33M Buy
6,335
+2,000
+46% +$609K 0.15% 110
2022
Q2 		$1.36M Hold
4,335
– – 0.19% 95
2022
Q1 		$1.65M Buy
+4,335
New +$1.7M 0.21% 90

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Pallas Capital Advisors's WST Position: Q2 2026 in Review

Pallas Capital Advisors reduced its West Pharmaceutical (WST) stake by 0.16% in Q2 2026, selling an estimated $3.06K and leaving 6,349 shares worth $2.28M. The position accounts for 0.07% of the portfolio, ranked #197.

Pallas Capital Advisors first reported a position in WST in Q1 2022 and has held it in 18 quarters since. The position peaked at $2.49M in Q1 2024. 832 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Pallas Capital Advisors held 6,349 shares of West Pharmaceutical worth $2.28M as of Q2 2026.
  • Pallas Capital Advisors sold 10 West Pharmaceutical shares in Q2 2026, an estimated $3.06K.
  • West Pharmaceutical made up 0.07% of Pallas Capital Advisors's portfolio in Q2 2026, its #197 holding.
  • Pallas Capital Advisors first reported a position in West Pharmaceutical in Q1 2022 and has held it in 18 quarters since.
  • Pallas Capital Advisors's West Pharmaceutical position peaked at $2.49M in Q1 2024.
  • 832 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Pallas Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.